Onset of Sarcoidosis in Patients on Biologic Therapy: A Systematic Review

J Cutan Med Surg. 2022 Sep-Oct;26(5):512-513. doi: 10.1177/12034754221100187. Epub 2022 May 19.

Authors

Yuliya Lytvyn¹, Asfandyar Mufti², Muskaan Sachdeva¹, Abrahim Abduelmula³, Ahmed Bagit⁴, Jensen Yeung^{2

5}

Affiliations

¹ 7938 Temerty Faculty of Medicine, University of Toronto, Canada.
² Division of Dermatology, University of Toronto, Canada.
³ 70384 Faculty of Medicine, University of Western Ontario, London, Canada.
⁴ 7497 Faculty of Health Sciences, Brock University, St. Catharines, ON, Canada.
⁵ Division of Dermatology, Women's College Hospital, Toronto, Canada.

PMID: 35588083
DOI: 10.1177/12034754221100187

No abstract available

Keywords: TNF-alpha inhibitor; anti-CD20; biologics; drug adverse reactions; sarcoidosis.

Publication types

Letter
Systematic Review
Research Support, Non-U.S. Gov't

MeSH terms

Antirheumatic Agents* / therapeutic use
Biological Products* / adverse effects
Biological Therapy
Etanercept / therapeutic use
Humans
Sarcoidosis* / chemically induced
Tumor Necrosis Factor-alpha

Substances

Antirheumatic Agents
Biological Products
Tumor Necrosis Factor-alpha
Etanercept